We are pioneering the Gene Pill™
– a platform to administer gene therapy as an oral drug.
enGene has developed a solution to the long-standing challenge of producing gene therapies that can be dosed orally and can penetrate mucosal tissues. Our Dually Derivitized Oligochitosan (DDX®) formulation is optimized to package and transport DNA into epithelial cells situated behind mucus barriers. Coupling this pioneering technology to our deep scientific know-how and dedicated team, we are passionately focused on making our vision a reality — creating simple and effective gene therapies for a healthier and higher quality of life.

We are pioneering the Gene Pill™
– a platform to administer gene therapy as an oral drug.

enGene has developed a solution to the long-standing challenge of producing gene therapies that can be dosed orally and can penetrate mucosal tissues. Our Dually Derivitized Oligochitosan (DDX®) formulation is optimized to package and transport DNA into epithelial cells situated behind mucus barriers. Coupling this pioneering technology to our deep scientific know-how and dedicated team, we are passionately focused on making our vision a reality — creating simple and effective gene therapies for a healthier and higher quality of life.